Aspire Biopharma Holdings (ASBP) Interest & Investment Income (2022 - 2024)
Aspire Biopharma Holdings' (ASBP) quarterly Interest & Investment Income came in at $169912.0 in Q2 2024, down 91.91% year-on-year from $2.1 million in Q3 2023, and down 27.65% on a QoQ basis from $234853.0 in Q1 2024.
Aspire Biopharma Holdings (ASBP) Interest & Investment Income (2022 - 2024) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 3 years of Interest & Investment Income data on file, last reported at $169912.0 in Q2 2024.
- On a quarterly basis, Interest & Investment Income fell 91.91% year-over-year to $169912.0 in Q2 2024; TTM through Jun 2024 was $920917.0, a 89.96% decrease from a year earlier, with the FY2024 full-year figure at $548676.0, down 90.56% from the prior year.
- Interest & Investment Income for Q2 2024 stood at $169912.0, down from $234853.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for ASBP reached as high as $3.2 million in Q1 2023 and fell as low as $21393.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.1 million across 3 years, with a median of $339600.5 in 2022.
- Across the five-year window, Interest & Investment Income jumped 14844.13% in 2023 and tumbled 92.65% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $2.5 million in 2022, then slumped by 89.75% to $260668.0 in 2023, then sank by 34.82% to $169912.0 in 2024.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $169912.0 in Q2 2024, $234853.0 in Q1 2024, and $260668.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 169,912.00 |
| Mar 31, 2024 | 234,853.00 |
| Dec 31, 2023 | 260,668.00 |
| Sep 30, 2023 | 255,484.00 |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 418,533.00 |
| Mar 31, 2022 | 21,393.00 |